Business Wire

DataXstream Announces OMS+ 4 for Faster Sales Execution Across SAP

Share

DataXstream LLC, an SAP® Endorsed app and Gold-level partner developing innovative solutions for SAP sales and distribution, today announced the fourth release of its award-winning OMS+ platform, which significantly accelerates quote and order processing capabilities within SAP S/4 HANA On-Premise and SAP S/4 HANA Private Cloud environments.

Faster Order and Document Transactions

McKinsey & Company reports that companies who leverage technology and automation for their sales teams report a 10-15% efficiency boost, which translates into more time with customers and less time on back-office tasks. (Source: McKinsey & Company, “An unconstrained future: How generative AI could reshape B2B sales”, September 16, 2024).

By integrating DataXstream’s OMS+ IA Intelligent Automation technology into the OMS+ 4 platform, B2B organizations will be able to immediately create and process orders from emails, PDFs, and Excel documents with minimal human touch – no separate add-on purchase required. The proprietary AI model will significantly reduce manual entry time and speedup quote and order creation.

AI Assistant for Increased Efficiency

Included in this release is an AI assistant that will assist sales and customer service reps by quickly retrieving customer and order information, reducing time spent on manual searches. This will allow them to focus on more on high-value activities.

Faster Implementation

The newest version of OMS+ enables faster, more seamless implementations which reduces complexity and allows organizations to quickly deploy the software and start realizing value sooner.

Large Language Model (LLM) Integration

Large Language Model (LLM) integration will now be standard in OMS+, giving organizations the ability to better understand and process unstructured data, such as email and PDFs, with greater accuracy and speed. This will greatly streamline workflows and allows companies to handle complex sales and order processes more efficiently.

Automated Material Matching

There is often a gap between how customers describe products and how it is represented in a company’s database. Most software requires an exact match, which greatly hinders and slows down the order process, especially on large quotes. OMS+ 4 allows organizations to identify and validate materials in SAP by matched logged data attributes using the proprietary AI model. Automated Material Matching reduces manual search time and ensures data accuracy and consistency.

Enhanced User Interface

The newest release of OMS+ features a redesigned, modern interface with intuitive navigation for enhanced usability. The thoughtfully designed UI also prioritizes inclusivity, ensuring the platform is usable by everyone to deliver a frictionless experience for users.

“I am extremely proud of this release and confident it will be a game-changer for SAP users who struggle with complex sales and order processes,” said Tim Yates, CEO, DataXstream. “By incorporating our intelligent automation and AI technology into the OMS+ platform, we are delivering a solution that is unmatched in the market today.”

DataXstream

DataXstream is an SAP® Gold and Endorsed App Partner dedicated to building solutions on emerging technologies that maximize the ROI of our customers’ SAP® infrastructure. As members of the SAP® marketplace, DataXstream’s products can be found in the SAP® Store. DataXstream’s OMS+ will revolutionize your organization’s sale and customer buying experience. www.dataxstream.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250106071385/en/

Contacts

Cailin Yates
CMO
757.345.3437
cyates@dataxstream.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release

Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn

Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release

Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of

500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release

500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa

Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release

Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la

Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release

Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye